UPDATE: ResMed Receives Permanent Injunction Against APEX In Germany, Continues Enforcement Of Patents in Europe
July 28, 2014 at 08:05 AM EDT
ResMed (NYSE: RMD), an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and other chronic ...